Corporate Banner
Satellite Banner
Immunology
Scientific Community
 
Become a Member | Sign in
Home>News

  News Archive

New Anti-Cancer Strategy Elicits Immune Response
Wednesday, July 06, 2016
Scientists have developed a vaccine that stimulates both an innate immune response and an adaptive response to combat cancer cell development.

Immune-Based Therapy In Mice Shows Promise Against Pancreatic Cancer
Wednesday, July 06, 2016
Clinical trial will test safety of new strategy in patients with advanced pancreatic tumors.

Morphosys Receives Novartis Milestone Payment for Phase 1 Trial
Tuesday, July 05, 2016
Company has received a milestone payment from Novartis for start of phase 1 trial in prevention of thrombosis with novel antibody.

Natural Metabolite Can Suppress Inflammation
Monday, July 04, 2016
An international group of scientists from US, Canada, Germany and Russia has revealed a substance produced in humans that can suppress the pro-inflammatory activity of macrophages – specific cells of immune system.

A New Therapy for Autoimmune Diseases
Monday, July 04, 2016
Preclinical study from Penn shows that engineered T cells can selectively target the antibody-producing cells that cause autoimmune disease.

Benign Bacteria Block Mosquitoes from Transmitting Zika, Chikungunya Viruses
Monday, July 04, 2016
Researchers at the University of Wisconsin–Madison have confirmed that a benign bacterium called Wolbachia pipientis can completely block transmission of Zika virus in Aedes aegypti, the mosquito species responsible for passing the virus to humans.

New CAR T Cell Therapy Using Double Target Aimed at Solid Tumors
Friday, July 01, 2016
Researchers at Penn University have described how antibody, carbohydrate combination could apply to range of cancer types.

Merck, Moderna Announce Strategic Collaboration
Friday, July 01, 2016
Collaboration combines Merck’s leadership in immuno-oncology with Moderna’s pioneering mrna vaccine technology and rapid cycle time, small-batch GMP manufacturing capabilities.

New Therapy Treats Autoimmune Disease Without Harming Normal Immunity
Friday, July 01, 2016
Preclinical study from Penn shows that engineered T cells can selectively target the antibody-producing cells that cause autoimmune disease.

<< 1 2 3 4 5 6 7 >>
Showing Results 31 - 40 of 1926
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!